| Patents for C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings (42,619) |
|---|
| 04/05/2006 | EP1641465A2 Combinations of an aryl aniline beta-2 adrenergic receptor agonist and a corticosteroid |
| 04/05/2006 | EP1357889B1 Novels couplers for use in oxidative hair dyeing |
| 04/05/2006 | EP1300398B1 Propane-1,3-dione derivatives |
| 04/05/2006 | EP1140846B1 Aspartic protease inhibitors |
| 04/05/2006 | CN1756754A Arylvinylazacycloalkane compounds and methods of preparation and use thereof |
| 04/05/2006 | CN1756553A 2-cyanopyrrolopyrimidines and pharmaceutical uses thereof |
| 04/05/2006 | CN1754877A Anthracene derivative and organic electroluminescence device using the derivative |
| 04/05/2006 | CN1754873A Aryl sulfonamides and analogues thereof and their use in the treatment of neurodegenerative diseases |
| 04/05/2006 | CN1249026C N-guanidinoalkylamides, their preparation, their use, and pharmaceutical preparations comprising them |
| 04/04/2006 | US7022870 Antidepressants; sexual disorders; anticancer agnets; hormone replacement therapy |
| 04/04/2006 | US7022851 A peptide nucleic acid derivatives comprising a N-acetyl-1-(2-nitro-phenensulfonyl)-peperazin-2-one core group; oligomerization, for specific binding to DNA as well as RNA, stability |
| 04/04/2006 | US7022849 Quinazoline and pyrido[2,3-d]pyrimidine inhibitors of phosphodiesterase (PDE) 7 |
| 04/04/2006 | US7022825 Polyketides and antibiotics |
| 04/04/2006 | US7022731 Cardiovascular disorders; thrombosis; anticoagulants |
| 04/04/2006 | US7022718 Pyridine and pyrimidine derivatives |
| 04/04/2006 | US7022220 for ethylenically unsaturated compounds |
| 04/04/2006 | CA2294624C Cationic monobenzene nitrophenylenediamines, their use in dying keratin fibres, dyeing compositions containing them and dyeing processes |
| 04/04/2006 | CA2256492C Diarylalkyl cyclic diamine derivatives as chemokine receptor antagonists |
| 04/04/2006 | CA2043976C Substituted phthalides and heterocyclic phthalides |
| 03/30/2006 | WO2006034235A2 Substituted quinoline and quinazoline inhibitors of quinone reductase 2 |
| 03/30/2006 | WO2006033844A2 4-arylspirocycloalkyl-2-aminopyrimidine carboxamide kcnq potassium channel modulators |
| 03/30/2006 | WO2005120515A3 Novel sulfonamides as inhibitors of histone deacetylase for the treatment of disease |
| 03/30/2006 | WO2005117867A3 Monocyclic heterocycles as kinase inhibitors |
| 03/30/2006 | WO2005037825A3 Protein kinase inhibitors |
| 03/30/2006 | WO2004053071A3 Method for discovering neurogenic agents |
| 03/30/2006 | US20060069259 N-(trans-2,3-di-n-amyl-2-butenoic acid amide)-L-phenylglycinamide;treating hypertension, deficiency of magnesium ion bound to the plasma membranes of their somatic cells; sodium-sensitive essential hypertension and Type 2 insulin-resistant diabetes mellitus |
| 03/30/2006 | US20060069106 inflammatory diseases, immune disorders, multiple sclerosis, rheumatoid arthritis, psoriasis; CXCR3 chemokine receptor modulators; 2-(4-fluoro-3-trifluoromethyl-phenyl)-N-(2-methanesulfonyl-ethyl)-N-(1-{4-oxo-3-[4-(2,2,2-trifluoro-ethoxy)-phenyl]-3,4-dihydro-pyrido[2,3-d]pyrimidin-2-yl}-ethyl)-acetamide |
| 03/30/2006 | US20060069077 Receptor-type kinase modulators and methods of use |
| 03/30/2006 | US20060069037 Peptide-containing alpha-ketoamide cysteine and serine protease inhibitors |
| 03/30/2006 | US20060068020 Encapsulated pharmaceutical agents |
| 03/30/2006 | DE102004046623A1 Neue Pyrimidin-Derivate und ihre Verwendung New pyrimidine derivatives and their use |
| 03/30/2006 | CA2582492A1 Novel pyrimidine derivatives and their use |
| 03/30/2006 | CA2581454A1 Novel pyrimidine compounds, process for their preparation and compositions containing them |
| 03/29/2006 | EP1640368A2 Cyclic ureas and processes for their preparation |
| 03/29/2006 | EP1638974A2 Triazolopyrimidines |
| 03/29/2006 | EP1638964A1 Novel compounds that modulate ppar-gamma type receptors, and use thereof in cosmetic or pharmaceutical compositions |
| 03/29/2006 | EP1638955A2 Pyrimidines useful as modulators of voltage-gated ion channels |
| 03/29/2006 | EP1638946A2 2-aminoethyl substituted pyrimidin-2-ones, cyclopropanes, pyrazolines, pyrimidines and benzothiazepines and their use as urotensin ii urotensini ii and somatostatins 5 receptor ligands |
| 03/29/2006 | EP1638945A1 Heterocyclically substituted pentanol derivatives, method for the production thereof, and use thereof as anti-inflammatory agents |
| 03/29/2006 | EP1638928A1 N-alkynyl-2-(substituted aryloxy)alkylthioamide derivatives as fungicides |
| 03/29/2006 | EP1638570A1 Pyrimidine derivatives as cannabinoid receptor ligands |
| 03/29/2006 | EP1461083B1 Combined therapy against tumors comprising substituted acryloyl distamycin derivatives and protein kinase (serine/threonine kinase) inhibitors |
| 03/29/2006 | EP1303270B1 Method for treating cryptorchidism |
| 03/29/2006 | CN1753892A Tetrahydro-4h-pyrido[1,2-a]pyrimidines and related compounds useful as HIV integrase inhibitors |
| 03/29/2006 | CN1753877A Compounds useful for treatment or prevention of disease mediated by alpha-2b-adrenoceptor |
| 03/29/2006 | CN1248033C Supertwisted nematic liquid crystal displays, liquid crystal compositions and compounds |
| 03/29/2006 | CN1247594C Bicyclic heteroaromatic compounds |
| 03/29/2006 | CN1247586C Substituted 2-pyrimidinyl-6,7,8,9-tetrahydropyrimido[1,2-A]pyrimidin-4-one and 7-pyrimidinyl-2,3-dihydroimidazo[1,2-A]pyrimidin-5(1H)one derivatives for neurodegenerative disorders |
| 03/29/2006 | CN1247584C I-[alkyl] 1-[(heteroaryl) alkyl] and 1 [(aryl) alkyl] 7-pyridinyl-imidazo [1,2-a] pyrimidin-5(1h)-one derivatives |
| 03/29/2006 | CN1247579C Synthesizing nucleoside analog for antivirus |
| 03/29/2006 | CN1247578C Dementia remedies containing 2-aryl-8-oxodihydropurine derivatives as the active ingredient |
| 03/29/2006 | CN1247569C Novel pyrimidyl sulfamide compounds with anti-tumor activity and their salts |
| 03/29/2006 | CN1247547C Piperidine and piperazine substituted N-hydroxyformamides as inhibitors of metalloproteinases |
| 03/29/2006 | CN1247529C Process for preparing N-aroyl-L-glutaminic acid |
| 03/28/2006 | US7019136 8-quinolinxanthine and 8-isoquinolinxanthine derivatives as PDE 5 inhibitors |
| 03/28/2006 | US7019012 Quinazoline derivatives and pharmaceutical compositions containing them |
| 03/28/2006 | US7019003 Bactericides |
| 03/28/2006 | US7019002 Substituted on 8th position with benzoic acid, ester or amide groups; anticancer agents |
| 03/28/2006 | US7019000 administering nitrogen-sulfur compounds, e.g. 4,4-dithiodimorpholine to inhibit binding of the E6 protein by human papilloma virus; treatment of cervical cancer |
| 03/28/2006 | US7018960 Formed by inter-molecular interaction of one or more keto-enol tautomeric compounds; for mechanical friction sliding members |
| 03/23/2006 | WO2006031852A1 Vanilloid receptor ligands and their use in treatments |
| 03/23/2006 | WO2006030906A1 Nucleoside analogues or salts thereof |
| 03/23/2006 | WO2006030211A2 Acyclic sulphonamides |
| 03/23/2006 | US20060063790 drugs such as 1,2,3,4-tetrahydro-2-[[2-(3-methyl-1-piperidinyl)-4-(1-phenylcyclopropyl)-5-pyrimidinyl]carbonyl]-isoquinoline and carriers administered as cognition activators |
| 03/23/2006 | US20060063789 Aminobenzamide derivatives as glycogen synthase kinase 3 beta inhibitors |
| 03/23/2006 | US20060063783 Sulphonylpiperidine derivatives containing an alkenyl or alkynyl moiety for use as matrix metalloproteinase inhibitors |
| 03/23/2006 | US20060063770 Nitrogenous heterocyclic compounds |
| 03/23/2006 | US20060063769 Preventives/remedies for urinary disturbance |
| 03/23/2006 | US20060063763 Compounds and methods for modulating CXCR3 function |
| 03/23/2006 | DE19547099B4 Verfahren zur Herstellung von (Meth)acrylsäureestern Acrylic acid esters, process for the preparation of (meth) |
| 03/23/2006 | CA2580020A1 Aryl spirolactam cgrp receptor antagonists |
| 03/23/2006 | CA2579847A1 Bicyclic anilide spirolactam cgrp receptor antagonists |
| 03/23/2006 | CA2579143A1 Vanilloid receptor ligands and their use in treatments |
| 03/22/2006 | EP1637523A1 Process for producing pyrimidin-4-one compound |
| 03/22/2006 | EP1636195A1 Quinazolines and pyrido[3,4-d]pyrimidines as receptor tyrosine kinase inhibitors |
| 03/22/2006 | EP1635909A2 Treatment of amyloid- and epileptogenesis-associated diseases |
| 03/22/2006 | EP1635846A2 Small molecule toll-like receptor (tlr) antagonists |
| 03/22/2006 | EP1635835A1 2-aminopyrimidine derivatives as raf kinase inhibitors |
| 03/22/2006 | CN1751046A Substituted hexahydropyrazino(1,2-a)pyrimidin-4,7-dion derivatives, method for the production and use thereof as medicaments |
| 03/22/2006 | CN1751033A Bicyclic heterocycles, medicaments containing said compounds, use thereof, and method for the production thereof |
| 03/22/2006 | CN1751032A Polymorph of {6,7-bis(2-methoxy-ethoxy)-quinazolin-4-yl}-(3e) |
| 03/22/2006 | CN1751031A HIV replication inhibiting pyrimidines and triazines |
| 03/22/2006 | CN1751030A HIV replication inhibiting pyrimidines and triazines |
| 03/22/2006 | CN1751029A 2-aminoethyl substituted pyrimidin-2-ones, cyclopropanes, pyrazolines, pyrimidines and benzothiazepines and their use as urotensin ii and somatostatin 5 receptor ligands |
| 03/22/2006 | CN1751024A Nitrogenous heterocyclic derivative and organic electroluminescent element employing the same |
| 03/22/2006 | CN1749250A Chemical synthetic method for 2-chloro-4-amino-6,7-dimethoxy quinazoline |
| 03/22/2006 | CN1245979C Preventive or therapeutic drugs for fibrosis containing chymase inhibitors as active ingredient |
| 03/22/2006 | CN1245978C Preventive or therapeutic drugs for various eosinophilia realated diseases containing chymase inhibitors as active ingredient |
| 03/21/2006 | US7015331 A compound selected from the group consisting of 1,2,3-benzotriazol-2-yl-L-alanine, 5-carboxy-1,2,3-benzotriazol-2-yl-L-alanine, and 5-carboxy-1,2,3-benzotriazol-1-yl-L-alanine. |
| 03/21/2006 | US7015230 serine protease inhibitors comprising pyrimidinediones, used as anticoagulants for prophylaxis of cardiovascular disorders; thrombolytic agents |
| 03/21/2006 | US7015229 An antagonist of a corticotropin releasing factor (CRF) receptor, treating central nervous system disorders or anxiety disorders, depression and stress |
| 03/21/2006 | US7015228 4-amino-2-(2-pyridyl)pyrimidines as microbicidal active substances |
| 03/21/2006 | US7015227 Amino -benzenes, -pyridines, -pyrimidines, -pyrazines, -pyridazines, -pyrazoles; anticancer agents |
| 03/21/2006 | US7015226 Hormone inhibitors such as 3-[2(R)-aminopropylamino-2-phenylethyl]-5-(2-fluoro-3-methoxyphenyl)-1-[2-fluoro-6-methylsulfonylbenzyl]-6-methyl-pyrimidine-2,4(1H,3H)-dione, used as anticarcinogenic agents and for prophylaxis of glandular or urogenital disorders |
| 03/21/2006 | US7015208 carbocyclic alcohols such as 5-Chloro-2-methylsulfonylindan-1-ol and isomers, used as anorexigenic agents; side effect reduction; nontoxic |
| 03/21/2006 | CA2315220C Integrin receptor antagonists |
| 03/21/2006 | CA2186285C Carbonyl containing compounds and their derivatives as multi-functional fuel and lube additives |
| 03/21/2006 | CA2072416C Cyclopropenone derivatives |
| 03/16/2006 | WO2006028904A1 Quinazolines useful as modulators of ion channels |
| 03/16/2006 | WO2006028833A1 Synthesis of 2,4-pyrimidinediamine compounds |